Fig. 3From: Molecular characterization of breast cancer: a potential novel immune-related lncRNAs signatureComparisons of the predictive accuracy between the immune-related lncRNAs model and TNM stage using time-dependent ROC curves in the primary cohort (a) and validation cohort (b). Comparisons of the clinical utility between the immune-related lncRNAs model and TNM stage using decision curve in the primary cohort (c) and validation cohort (d)Back to article page